BACKGROUND: Recipients of ICD are likely to have several risk factors that could interfere with successful use of implantable cardioverter defibrillators (ICDs). HYPOTHESIS: Age, sex, and factors indicated in claims are associated with one-year mortality and complications after ICD placement. METHODS: Adult Medicare Advantage patients who underwent outpatient ICD implantation from January 2014 to September 2015 were included. Age, sex, Charlson Comorbidity Index (CCI), prior year hospitalization and emergency department (ED) visit, diabetes, heart failure, ischemic heart disease, and indicators of the need for pacing were evaluated as risk factors. Mortality and device-related complications (lead and nonlead) were assessed at one-year post-procedure using Kaplan-Meier and Cox Proportional Hazard analysis. RESULTS: Among 8450 patients who underwent implantation, 1-year event-free survival was 80.1%, based on an overall composite measure of complications and mortality. Adjusted survival analysis showed that age ≥ 65, male sex, incremental increase in CCI, heart failure, prior year hospitalization, ED visit, and prior year pacing procedure were significant predictors of mortality. Age ≥ 65, male sex, and prior year hospitalization were significant predictors of a composite measure of device-related complications. CCI and prior hospitalization were significant predictors of a composite measure of any adverse outcome. CONCLUSIONS: Results suggest most patients in an older population do not experience adverse outcomes in the year following ICD implantation. The risk of mortality may be greater in men, patients over the age of 65, and patients with greater general morbidity, heart failure, or a history of a pacing procedure.
BACKGROUND: Recipients of ICD are likely to have several risk factors that could interfere with successful use of implantable cardioverter defibrillators (ICDs). HYPOTHESIS: Age, sex, and factors indicated in claims are associated with one-year mortality and complications after ICD placement. METHODS: Adult Medicare Advantage patients who underwent outpatientICD implantation from January 2014 to September 2015 were included. Age, sex, Charlson Comorbidity Index (CCI), prior year hospitalization and emergency department (ED) visit, diabetes, heart failure, ischemic heart disease, and indicators of the need for pacing were evaluated as risk factors. Mortality and device-related complications (lead and nonlead) were assessed at one-year post-procedure using Kaplan-Meier and Cox Proportional Hazard analysis. RESULTS: Among 8450 patients who underwent implantation, 1-year event-free survival was 80.1%, based on an overall composite measure of complications and mortality. Adjusted survival analysis showed that age ≥ 65, male sex, incremental increase in CCI, heart failure, prior year hospitalization, ED visit, and prior year pacing procedure were significant predictors of mortality. Age ≥ 65, male sex, and prior year hospitalization were significant predictors of a composite measure of device-related complications. CCI and prior hospitalization were significant predictors of a composite measure of any adverse outcome. CONCLUSIONS: Results suggest most patients in an older population do not experience adverse outcomes in the year following ICD implantation. The risk of mortality may be greater in men, patients over the age of 65, and patients with greater general morbidity, heart failure, or a history of a pacing procedure.
Authors: Paul L Hess; Sana M Al-Khatib; Joo Y Han; Rex Edwards; Gust H Bardy; J Thomas Bigger; Alfred Buxton; Riccardo Cappato; Paul Dorian; Al Hallstrom; Alan H Kadish; Peter J Kudenchuk; Kerry L Lee; Daniel B Mark; Arthur J Moss; Richard Steinman; Lurdes Y T Inoue; Gillian Sanders Journal: Circ Cardiovasc Qual Outcomes Date: 2015-02-10
Authors: Daniel J Friedman; Craig S Parzynski; Paul D Varosy; Jordan M Prutkin; Kristen K Patton; Ali Mithani; Andrea M Russo; Jeptha P Curtis; Sana M Al-Khatib Journal: JAMA Cardiol Date: 2016-11-01 Impact factor: 14.676
Authors: Michael R Gold; Dominic A Theuns; Bradley P Knight; J Lacy Sturdivant; Rick Sanghera; Kenneth A Ellenbogen; Mark A Wood; Martin C Burke Journal: J Cardiovasc Electrophysiol Date: 2011-10-28
Authors: J Kron; J Herre; E G Renfroe; C Rizo-Patron; M Raitt; B Halperin; M Gold; B Goldner; M Wathen; B Wilkoff; A Olarte; Q Yao Journal: Am Heart J Date: 2001-01 Impact factor: 4.749
Authors: Sana M Al-Khatib; Gregg C Fonarow; Jose A Joglar; Lurdes Y T Inoue; Daniel B Mark; Kerry L Lee; Alan Kadish; Gust Bardy; Gillian D Sanders Journal: JAMA Cardiol Date: 2017-06-01 Impact factor: 14.676
Authors: Douglas S Lee; Jack V Tu; Peter C Austin; Paul Dorian; Raymond Yee; Alice Chong; David A Alter; Andreas Laupacis Journal: J Am Coll Cardiol Date: 2007-06-11 Impact factor: 24.094
Authors: Benjamin A Steinberg; Sana M Al-Khatib; Rex Edwards; JooYoon Han; Gust H Bardy; J Thomas Bigger; Alfred E Buxton; Arthur J Moss; Kerry L Lee; Richard Steinman; Paul Dorian; Alfred Hallstrom; Riccardo Cappato; Alan H Kadish; Peter J Kudenchuk; Daniel B Mark; Lurdes Y T Inoue; Gillian D Sanders Journal: JACC Heart Fail Date: 2014-10-08 Impact factor: 12.035
Authors: Amr F Barakat; Marwan Saad; Akram Y Elgendy; Amgad Mentias; Ahmed Abuzaid; Ahmed N Mahmoud; Islam Y Elgendy Journal: BMJ Open Date: 2017-06-21 Impact factor: 2.692
Authors: Matthew J Shun-Shin; Sean L Zheng; Graham D Cole; James P Howard; Zachary I Whinnett; Darrel P Francis Journal: Eur Heart J Date: 2017-06-07 Impact factor: 29.983
Authors: Teresa L Rogstad; Adam C Powell; Yongjia Song; Tristan Cordier; Stephen E Price; James W Long; Uday U Deshmukh; Jeffrey D Simmons Journal: Clin Cardiol Date: 2018-09-20 Impact factor: 2.882